Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Shares Issued (2016 - 2022)

Vanda Pharmaceuticals' Shares Issued history spans 12 years, with the latest figure at $571000.0 for Q4 2022.

  • For Q4 2022, Shares Issued fell 47.66% year-over-year to $571000.0; the TTM value through Dec 2023 reached $600000.0, down 14.29%, while the annual FY2022 figure was $700000.0, 80.56% down from the prior year.
  • Shares Issued for Q4 2022 was $571000.0 at Vanda Pharmaceuticals, up from $29000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $100.9 million in Q1 2018 and bottomed at -$95.5 million in Q2 2018.
  • The 5-year median for Shares Issued is $500000.0 (2019), against an average of $1.2 million.
  • The largest YoY upside for Shares Issued was 4467.68% in 2018 against a maximum downside of 4456.95% in 2018.
  • A 5-year view of Shares Issued shows it stood at $800000.0 in 2018, then soared by 175.0% to $2.2 million in 2019, then tumbled by 34.82% to $1.4 million in 2020, then decreased by 23.92% to $1.1 million in 2021, then tumbled by 47.66% to $571000.0 in 2022.
  • Per Business Quant, the three most recent readings for VNDA's Shares Issued are $571000.0 (Q4 2022), $29000.0 (Q3 2022), and $100000.0 (Q2 2022).